BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
11.70
-0.12 (-1.02%)
Sep 26, 2025, 4:00 PM EDT - Market closed
BBOT Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -87.5 | -74.28 | -64.7 |
| Depreciation & Amortization | 0.34 | 0.21 | 0.09 |
| Loss (Gain) From Sale of Investments | -2.13 | -1.54 | - |
| Stock-Based Compensation | 2.86 | 4.43 | 16.47 |
| Other Operating Activities | 1.29 | 0.56 | - |
| Change in Accounts Payable | 1.46 | 2.5 | 0.27 |
| Change in Other Net Operating Assets | 2.78 | 13.1 | -4.2 |
| Operating Cash Flow | -80.9 | -55.03 | -52.08 |
| Capital Expenditures | -0.41 | -0.05 | -0.41 |
| Investment in Securities | 54 | -122.89 | - |
| Other Investing Activities | - | 2.41 | -2.41 |
| Investing Cash Flow | 53.59 | -120.53 | -2.82 |
| Issuance of Common Stock | 0.05 | 1.11 | 3.62 |
| Financing Cash Flow | 18.6 | 206.29 | 55.12 |
| Net Cash Flow | -8.71 | 30.73 | 0.23 |
| Free Cash Flow | -81.31 | -55.08 | -52.49 |
| Free Cash Flow Per Share | -249.57 | -379.51 | -420.87 |
| Levered Free Cash Flow | - | -42.53 | - |
| Unlevered Free Cash Flow | - | -42.53 | - |
| Change in Working Capital | 4.24 | 15.59 | -3.94 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.